These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 38783892)

  • 21. Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells.
    Montero-Montero L; Renart J; Ramírez A; Ramos C; Shamhood M; Jarcovsky R; Quintanilla M; Martín-Villar E
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.
    Preca BT; Bajdak K; Mock K; Sundararajan V; Pfannstiel J; Maurer J; Wellner U; Hopt UT; Brummer T; Brabletz S; Brabletz T; Stemmler MP
    Int J Cancer; 2015 Dec; 137(11):2566-77. PubMed ID: 26077342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line.
    Asai R; Tsuchiya H; Amisaki M; Makimoto K; Takenaga A; Sakabe T; Hoi S; Koyama S; Shiota G
    Cancer Med; 2019 Feb; 8(2):773-782. PubMed ID: 30636370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse model.
    Hiraga T; Nakamura H
    Oncol Lett; 2016 Oct; 12(4):2962-2969. PubMed ID: 27698884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression.
    Bourguignon LY; Zhu D; Zhu H
    Front Biosci; 1998 Jul; 3():d637-49. PubMed ID: 9634539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A CD44v
    Hu J; Li G; Zhang P; Zhuang X; Hu G
    Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
    Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
    Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44.
    Spadea A; Rios de la Rosa JM; Tirella A; Ashford MB; Williams KJ; Stratford IJ; Tirelli N; Mehibel M
    Mol Pharm; 2019 Jun; 16(6):2481-2493. PubMed ID: 31013093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression.
    Iczkowski KA; Omara-Opyene AL; Shah GV
    Anticancer Res; 2006; 26(4B):2863-72. PubMed ID: 16886606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of CD44 isoforms in normal human liver and also in regenerative and neoplastic liver changes].
    Seelentag WK; Flury R; Schmid M; Komminoth P; Saremaslani P; Günthert U; Heitz PU; Roth J
    Verh Dtsch Ges Pathol; 1995; 79():144-7. PubMed ID: 8600679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage.
    Gasbarri A; Del Prete F; Girnita L; Martegani MP; Natali PG; Bartolazzi A
    Melanoma Res; 2003 Aug; 13(4):325-37. PubMed ID: 12883358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of alternative splicing of CD44 in cancer.
    Prochazka L; Tesarik R; Turanek J
    Cell Signal; 2014 Oct; 26(10):2234-9. PubMed ID: 25025570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional and clinical relevance of CD44 variant isoform expression on B-cell chronic lymphocytic leukemia cells.
    Zarcone D; De Rossi G; Tenca C; Marroni P; Mauro FR; Cerruti GM; Albi N; Fiorucci S; Velardi A; Grossi CE
    Haematologica; 1998 Dec; 83(12):1088-98. PubMed ID: 9949626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
    Fichtner I; Dehmel A; Naundorf H; Finke LH
    Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling.
    Zeilstra J; Joosten SP; van Andel H; Tolg C; Berns A; Snoek M; van de Wetering M; Spaargaren M; Clevers H; Pals ST
    Oncogene; 2014 Jan; 33(5):665-70. PubMed ID: 23318432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.
    Stauder R; Eisterer W; Thaler J; Günthert U
    Blood; 1995 May; 85(10):2885-99. PubMed ID: 7537983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis.
    Dzobo K; Sinkala M
    OMICS; 2021 May; 25(5):313-332. PubMed ID: 33961518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells.
    Zöller M
    Front Immunol; 2015; 6():235. PubMed ID: 26074915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression.
    Brown RL; Reinke LM; Damerow MS; Perez D; Chodosh LA; Yang J; Cheng C
    J Clin Invest; 2011 Mar; 121(3):1064-74. PubMed ID: 21393860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.